Organovo Holdings, Inc.
ONVO
Classifica tra le azioni
#36036
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Prezzo delle azioni
$2.00
Ultima sincronizzazione: 2025-05-19
Capitalizzazione di mercato
$2.93M
Variazione (1 giorno)
-3.38%
Variazione (1 anno)
656.14%
Paese
US
Scambia Organovo Holdings, Inc. (ONVO)
Categoria
Healthcare
Storico del prezzo dell'azione per Organovo Holdings, Inc. (ONVO)
Prezzo di chiusura più alto: $5.13 il 2025-03-01
Prezzo di chiusura più basso: $131.45 il 2014-11-01
Prezzo di chiusura più basso: $131.45 il 2014-11-01
Storico del prezzo dell'azione di Organovo Holdings, Inc. dal 2014 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.10 | -4.29% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
